[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Indexing & Abstracting::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Creative commons

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


Search published articles

Showing 6 results for Najafi

Saeid Khamnei , Nahid Ghandchilar, Hooshang Najafi, Mahdi Farhoudi,
Volume 6, Issue 1 (spring 2006)

 Background & Objectives: Many researches have been conducted on autoregulation of cerebral blood flow (CBF), but its possible variations coincidence with postvagal tachycardia have not yet been studied. The present study searched for the effect of this phenomenon on CBF in young and middle-aged persons.

 Methods: 52 healthy volunteers including 13 young males (mean age 23.9±0.8), 13 young females (mean age 24.2±0.7), 13 middle-aged males (mean age 58±0.9) and 13 middle-aged females (mean age 56.4±0.7) went under the study. Flow velocity in middle cerebral artery (MCA) was assessed using transcranial Doppler (TCD) ultrasonography apparatus. Eckberg’s neck suction device was utilized to stimulate carotid baroreceptors. The data were analyzed using Minitab and SPSS software (rel. 10).

 Results: Concomitant to the carotid baroreceptors stimulation there was a significant reduction in heart rate in all groups (p<0.05), but mean cerebral blood flow did not change significantly. After ending the carotid baroreceptors stimulation and concomitant to PVT, mean cerebral blood flow increased in all groups except middle-aged males. This increase in CBF became significant in middle-aged females (p<0.05).

 Conclusion: The results of the present study indicate that cerebral blood flow autoregulation act effectively concomitant to acute stimulation of carotid baroreceptors and this efficacy is maintained until the middle-age, but when faced with PVT, cerebral blood flow autoregulation dose not act effectively.

Moslem Najafi, Tahereh Eteraf, Alireza Garjani,
Volume 8, Issue 1 (Spring 2008)

Background & Objective: Some studies have shown the protective effects of Etomoxir and Ranolazine in the hypoxic and ischemic condition of the heart. However, at present, there has not been any comparative study between the effects of Etomoxir and Ranolazine on
ischemia/reperfusion injuries (esp. infarct size), So their effects on infarct size in the ischemic isolated rat heart were studied and  compared.
Methods: Isolated rat hearts were divided into 3 groups randomly (n=6 in each group) and mounted on a Langendorff apparatus then perfused by a modified Krebs-Henseleit solution. In control group, the hearts were perfused by the solution at stabilization, 30min regional ischemia and 120min reperfusion while in the test groups they were perfused by enriched Krebs solution with 1μM of Etomoxir or 20μM of Ranolazine during ischemia/reperfusion. At the end of reperfusion, Evans Blue solution was infused to stain the non-ischemic area. Then the heart was incubated in 1% thriphenyl tetrazolium chloride solution and fixed by formalin. The infarct size was determined by a computerized planimetry package.
Results: The results showed that Etomoxir results in the significant decrease in the size of infracted area. In the control group, infarct size was 6.3±2.9%, while Etomoxir reduced infarct size to 20.9±5% (p< 0.01). Perfusion of the hearts by Ranolazine enriched Krebs solution produced greater reduction in infarct size (16.4±3.6%, p< 0.001). The effect was not statistically significant between the test groups.
Conclusion: It seems that Etomoxir (an inhibitor of fatty acid uptake by mitochondria) and Ranolazine (an inhibitor of fatty acid oxidation by mitochondria) probably, by indirect increasing of glucose oxidation, duning ischemia and reperfusion, may improve reperfusion recovery of ischemic heart and reduce infarct size. The results showed protective effects of Etomoxir and Ranolazine on infarct size without any significant difference between them.
Mohammad Dehgan, Neghin Akbari, Nazila Alborzi, Leili Najafi,
Volume 8, Issue 3 (Autumn 2008)

Background & Objectives: Even though there are different treatments for patients with pityriasis versicolor, there are not enough information about using new topical systemic treatments. In this study, the effect of clotrimazole VS topical fluconazole in treating patients with pityriasis was investigated.
Methods: A double blind randomized controlled trial was designed in dermatologic clinic of 5th Azar hospital Gorgan North of Iran, from April 2006 to May 2007. 120 patients were randomly divided into two groups: In the first group (G1), patients underwent treatment with single - dose of fluconazole capsule (400mg) and placebo cream. In the second group (G2), patients underwent treatment with clotrimazole cream (twice daily) and placebo capsule. The course of treatment was 2 weeks. All subjects were re-evaluated 2, 4 and 12 weeks after the end of the therapeutic course.
Results: In group one there were 50 patients and in group two 55. After 2 weeks, the rate of complete resolution of disease was significantly higher in G2 group than G1 (49.1% vs. 30%). After 4 weeks, 41 patients (81.2%) of G1 and 52 patients (94.9%) of G2 showed complete resolution. After 12 weeks 46 patients (92%) in G1 group and 45 patients (81.8%) in G2 group showed complete resolution. Recurrence rate in G1 and G2 groups were 6% and 18.2%, respectively. No complications were seen in the two groups.
Conclusion: In this study, clinical response at 4th week, in clotrimazole group was greater than fluconazole group. Recurrence at 12th week after treatment with oral fluconazole was less than clotrimazole cream.
Atefeh Ghanbari, Akramosadat Montazeri , Maryam Niknami , Zahra Atrkarroshan , Abdolrasool Sobhani, Behrooz Najafi,
Volume 10, Issue 4 (winter 2010)

 Background and objectives: Chemotherapy-induced nausea and vomiting are the most important complications for cancer patients. Ginger is an effective herbal drug for the treatment of nausea and vomiting. It hasn’t any known side effects. In some countries, it is used for making of antiemetic drugs. The aim of this study was to determine the effect of ginger on the intensity of chemotherapy-induced nausea and vomiting in cancer patients .

 Method: This study is a randomized, cross-over, double – blinded, clinical trial that was done on 44 cancer patients undergone chemotherapy. In the first cycle of the study, patients were assigned by four block random allocation to receive one of the antiemetic regimens regimen A (routine and 1gr ginger) and regimen B (routine and 1gr placebo). After 28 days, in the next cycle of chemotherapy, another regimen was administrated A or B plus chemotherapy drugs., the severity of the nausea and vomiting was measured in 4h (1, 2, 3, 4) after second dose and at the end of the 24h after receiving the first dose by using VAS and kortila tools .The data were analyzed by independent student t - test and non-parametric test (Mann-Whitney U test) by using SPSS, version 16 software .

 Results: The results showed that the frequencies of nausea and vomiting in two regimen groups weren’t different, but nausea score was significantly decreased in ginger group, compared to placebo. Independent student t - test and Mann-Whitney U test also revealed a significant difference on nausea scores in 3rd and 24th hour post chemotherapy (p=0.06, p=0.01, respectively).

 Conclusion: In respect to low nausea score in ginger regimen, compared to placebo, it seems ginger using is a safe and simple method and it can be used as antiemetic drugs in patient undergoing chemotherapy

Asadollah Asadi , Arash Abdolmaleki, Farhood Najafi,
Volume 13, Issue 1 (spring 2013)

  Background & Objectives: Polymers as drug carriers are recent advances in drug delivery and led to the new advent field that called polymer treatment. In the present study, the toxic and teratogenic effects of BDP18 were evaluated against chicken embryos as a model.

  Methods: The BDP18 tri-block copolymer (PLA-PEG2000-PLA) was synthesized. The compound solution was injected in triplicate examination, in the air sac of the eggs, at third day of incubation, and survived fraction of the embryos and Morphological and skeletal changes were recorded .

  Results: The survived fraction of the embryos depends on the compound concentration. In concentration of 20 mg/ml , 33.3% of the embryos were survived and the LD50 was 10.87 mg/egg . Morphological study of the treated embryos showed no abnormalities in embryos , and skeletal staining showed the deletion of caudal vertebrate in high concentration.

  Conclusion: The BDP18 copolymer had low toxic and teratogenic effects against the embryos, but it caused the deletion of caudal vertebrate at concentrations above the threshold (10 mg/ml). This polymer can be used as an effective drug -release system in low concentrations .

Mohammad Mehdi Zangeneh, Nader Goodarzi, Akram Zangeneh, Fariba Najafi, Reza Tahvilian,
Volume 17, Issue 4 (winter 2018)

Background & objectives: Considering the prevalence of diabetes and importance of its prevention, control and treatment, using low-calorie natural sweetener is necessary. Hepatoprotective and antidiabetic properties of the aqueous extract of Stevia. rebaudiana were assessed in the present study.
Methods: In this study, 35 mature male mice were divided into 5 groups. Diabetes was induced by administration of 60 mg/kg of streptozotocin intraperitoneally. The negative control group received normal saline and treatment groups received glibenclamide with 0.5 mg/kg and 200 and 400 μg/kg of aqueous extract of S. rebaudiana through gavage for 15 days, respectively. Also, one group was considered as positive control (as non-treated diabetic). On the last day, the blood glucose levels of samples were measured. After periodic acid Schiff (PAS) staining, 5μm of sections were used for stereological analysis. 
Results: The blood glucose level was decreased (p<0.05) significantly in aqueous extract-treated groups compared to the untreated diabetic mice. The weight and volume of kidneys, cortex, medulla, proximal and distal tubules, collecting ducts, loop of henle, interstitial tissues, vessels and length of renal tubules decreased significantly (p<0.05) after treatment with aqueous extract of S. rebaudiana (p<0.05). The number and volume of glomeruli restored toward normal levels with high doses of S. rebaudiana.
Conclusion: According to the obtained results, aqueous extract of S. rebaudiana (sweet fraction) can regulate the blood glucose levels and inhibit diabetes-induced renal damages. It seems that S. rebaudiana can be used as an antidiabetic and nephroprotective supplement.

Page 1 from 1     

مجله دانشگاه علوم پزشکی اردبیل Journal of Ardabil University of Medical Sciences
Persian site map - English site map - Created in 0.14 seconds with 34 queries by YEKTAWEB 3925